Clinical Trials Directory

Trials / Sponsors / Cyclerion Therapeutics

Cyclerion Therapeutics

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Solub
Healthy
Phase 12019-05-03
CompletedA Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Praliciguat in Healthy Male Volunteers
Healthy Volunteers
Phase 12019-03-01
CompletedA Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Olinciguat in Healthy Male Volunteers
Healthy Volunteers
Phase 12019-01-17
CompletedA Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of Pralicigu
Healthy
Phase 12018-04-12
CompletedA Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients Wi
Sickle Cell Disease
Phase 22017-12-22
TerminatedStudy of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II Achalasia
Achalasia
Phase 22017-04-06
CompletedTrial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC) in Patients With Stable Type 2 Diabetes and
Diabetes Mellitus, Type 2, Hypertension
Phase 22017-02-28
CompletedA Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Di
Diabetes Mellitus, Type 2, Hypertension
Phase 22016-09-01
CompletedA Trial of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Healthy Subjects
Healthy
Phase 12016-05-01
CompletedTrial of IW-1973 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers
Healthy
Phase 12015-11-01
CompletedTrial of IW-1701 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers
Healthy
Phase 12015-10-01